PAHO Instagram Features
Montevideo, 12 May 2022 (PAHO) - One in three pregnant women with COVID-19 who should have had access to an intensive care unit during the first two years of the pandemic failed to receive critical care, according to a collaborative research led by the Pan American Health Organization (PAHO) in eight Latin American countries and recently published…
Young people and heavy drinkers major targets
10 May 2022- A new report from the World Health Organization highlights the increasing use of sophisticated online marketing techniques for alcohol and the need for more effective regulation. It shows that young people and heavy drinkers are increasingly targeted by alcohol advertising, often to the…
On 15 April 2022, the World Health Organization (WHO) published an alert on severe acute hepatitis cases of unknown origin in children in the United Kingdom. Since then, there have been continuing additional reports of cases.
We spoke with Dr. Leandro Soares Sereno, Advisor for Viral Hepatitis Prevention and Control at the Pan American…
But while some countries of the region have the highest coverage in the world, others lag behind.
Washington D.C. 20 April 2022 (PAHO) – Over two-thirds of people in Latin America and the Caribbean have now received two doses of COVID-19 vaccine while some countries have yet to reach even half of their populations, said the Pan American Health…
In the Department of Cordillera, 60 kilometers from Paraguay's capital, the gap in access to information, diagnosis and treatment of cervical cancer is closing. Health personnel are moving beyond hospitals to raise awareness on this disease, which kills one woman every day in Paraguay.
PAHO calls for detection of all cases and equitable access to care for this disease, which causes about 30,000 new infections each year.
Washington, DC, April 13, 2022 (PAHO)- Due to its silent nature, less than 10% of those infected with Chagas disease each year receive timely diagnosis and, therefore, effective treatment in Mexico, Central…
Geneva, 11 April 2022 (WHO)- The 4-7 April convening of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been emerging over past years that single-dose schedules provide comparable efficacy to the two or three-dose regimens.
SAGE’s review concluded that a single-dose Human Papillomavirus (HPV)…